Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 450.0 | 67 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 246.5 | 68 | |
N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 259.0 | 70 | |
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 196.0 | 63 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 199.5 | 64 | |
RA2159 | 3 | M-CSF | 0 | ||||||||
RA2159 | PD184352 | 0.1 | uM | 3 | M-CSF | 0 | |||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | M-CSF | 0 | |||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | M-CSF | 0 | |||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 0 | |||||
RA2159 | IKK16 | 2.0 | uM | 3 | M-CSF | 0 | |||||
RA2159 | 3 | M-CSF | 0 | ||||||||
N2586 | 3 | M-CSF | 0 | ||||||||
N2586 | PD184352 | 0.1 | uM | 3 | M-CSF | 0 | |||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | M-CSF | 0 | |||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | M-CSF | 0 | |||||
N2586 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 0 | |||||
N2586 | IKK16 | 2.0 | uM | 3 | M-CSF | 0 | |||||
N2586 | 3 | M-CSF | 0 | ||||||||
RA2159 | Visfatin | 1 | ng/mL | 3 | M-CSF | 196.0 | 74 | ||||
RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 3 | M-CSF | 142.0 | 83 | |
RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | M-CSF | 101.0 | 71 | |
RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | M-CSF | 125.0 | 55 | |
RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | M-CSF | 121.5 | 68 | |
RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | M-CSF | 116.0 | 63 |